July 28, 2026

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 12% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the U.S. healthcare sector, is making waves with its innovative approach to non-opioid pain management solutions. With a market capitalization of..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22% Potential Upside

Investors seeking opportunities in the healthcare sector may find U.S. Physical Therapy, Inc. (NYSE: USPH) an intriguing prospect. This Houston-based company, with a market capitalization of $1.17 billion, operates within..

Ligand Pharmaceuticals Inc. (LGND) Stock Analysis: Exploring the 8.67% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has captured the attention of investors with its strong presence in the biotechnology sector, bolstered by an impressive 8.67% potential upside according to analyst ratings...

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential 138% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor interest with its innovative approach to cancer treatment through cutting-edge immunotherapies. Headquartered in San Diego,..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 165% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has caught the eye of investors with its promising potential upside of 165.50%, as indicated by analysts’ average target price. As a clinical-stage biopharmaceutical company,..

GRAIL, Inc. (GRAL) Investor Outlook: Exploring the 28.10% Revenue Growth Potential

GRAIL, Inc. (NASDAQ: GRAL) is carving its niche in the burgeoning healthcare sector, specifically within the diagnostics and research industry. Known for its innovative multi-cancer early detection tests, GRAIL is..

AtriCure, Inc. (ATRC) Stock Analysis: 25.77% Potential Upside in the Medical Instruments Sector

AtriCure, Inc. (NASDAQ: ATRC), a notable player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors with its significant potential upside of 25.77%...

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 66.67% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA) is capturing the attention of investors with its strategic positioning in the biotechnology sector, and a particularly enticing potential upside of 66.67%. With a market capitalization..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 32.87% Potential Upside with a Focus on Innovative Biotech Solutions

Belite Bio, Inc (BLTE) is creating waves in the biotechnology sector, capturing investor attention with a compelling potential upside of 32.87%. This clinical-stage biopharmaceutical company, based in San Diego, California,..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Evaluating Stability in the Biotech Sector

Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the biotechnology sector, is making waves with its focus on developing medicines for rare diseases in the United States. With a market..

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 4,158% Revenue Growth and Its Impact on Future Prospects

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical leader in developing treatments for rare cardiopulmonary diseases, has recently caught the attention of investors with its impressive financial metrics and promising pipeline. With..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: High ROE and Revenue Growth Signal Promising Prospects

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is carving out a notable presence in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna offers a..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Capitalizing on a 40% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, specializes in the development and manufacturing of branded and generic pharmaceutical products. With a market cap of $1.78..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Potential 132% Upside in Biotech

Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing opportunity for investors with a keen interest in the biotechnology sector. This clinical-stage company, headquartered in Brisbane, California, focuses on developing transformative..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator with Compelling Revenue Growth and Analyst Confidence

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, is gaining attention for its noteworthy performance metrics and robust analyst ratings. Headquartered..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Navigating Challenges with a $6.27 Billion Market Cap

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a biotechnology company focused on orexin-based neuroscience therapeutics, presents a fascinating case for investors intrigued by the potential of emerging healthcare solutions. Headquartered in Altrincham,..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with Virtual Healthcare Potential

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in the virtual healthcare landscape, finds itself at a critical juncture. With a market capitalization of $1.61 billion, this health information services company..

Kiniksa Pharmaceuticals Interna (KNSA) Investor Outlook: Analyzing a 10% Upside Potential in the Biopharma Sector

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) stands out as a compelling player within the healthcare sector, specifically in the drug manufacturing domain. With a robust market capitalization of $4.89 billion,..

Enovis Corporation (ENOV) Stock Analysis: A 44% Potential Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the medical devices industry, presents an intriguing opportunity for investors looking to capitalize on its potential growth in the healthcare sector. With..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds